The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 13, 2024
Filed:
May. 26, 2022
Applicant:
3d Systems, Inc., Rock Hill, SC (US);
Inventor:
Khalil Moussa, Chapel Hill, NC (US);
Assignee:
3D SYSTEMS, INC., Rock Hill, SC (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C08F 2/46 (2006.01); C08F 2/50 (2006.01); C08G 61/04 (2006.01); B29C 64/124 (2017.01); B33Y 10/00 (2015.01); C08F 20/28 (2006.01); C08F 20/36 (2006.01); C09D 11/101 (2014.01); C09D 11/104 (2014.01); B22F 10/12 (2021.01); B33Y 70/10 (2020.01); B33Y 70/00 (2020.01); B33Y 80/00 (2015.01); C08K 5/00 (2006.01); B22F 12/63 (2021.01); B22F 10/40 (2021.01);
U.S. Cl.
CPC ...
B29C 64/124 (2017.08); B22F 10/12 (2021.01); B33Y 10/00 (2014.12); B33Y 70/10 (2020.01); C08F 20/28 (2013.01); C08F 20/36 (2013.01); C09D 11/101 (2013.01); C09D 11/104 (2013.01); B22F 10/40 (2021.01); B22F 12/63 (2021.01); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); C08K 5/0025 (2013.01);
Abstract
In one aspect, inks for use with a three-dimensional (3D) printing system are described herein. In some embodiments, an ink described herein comprises 20-60 wt. % oligomeric curable material; 10-50 wt. % cyclocarbonate (meth)acrylate monomer; and 0.1-5 wt. % photoinitiator, based on the total weight of the ink. Additionally, in some cases, the ink further comprises one or more additional curable materials differing from the oligomeric curable material and the cyclocarbonate (meth)acrylate monomer. An ink described herein, in some embodiments, also comprises one or more additional component that are non-curable.